The World Health Organization (WHO) has recognized obesity as one of the top ten threats
to human health. It is estimated that the number of obese and overweight people worldwide …

Numerous scientific studies in recent years have shown significant skin and gut dysbiosis
among patients with psoriasis. A significant decrease in microbiome alpha-diversity …

This review summarizes existing research on the gut microbiome composition and function
in psoriasis and psoriatic arthritis, exploring potential roles in disease pathogenesis …

Obesity is a growing epidemic worldwide, and it is also considered a major environmental
factor contributing to the pathogenesis of inflammatory skin diseases, including psoriasis …

Psoriasis is a chronic skin immune-mediated disease with systemic pro-inflammatory
activation; both genetic and lifestyles factors contribute to its pathogenesis and severity. In …

Background: Patients with plaque psoriasis have an increased risk of metabolic syndrome.
However, no studies have assessed the nutritional status or screening methods of this …

Psoriasis is one of the most common inflammatory skin diseases affecting about 1–3% of the
population. One of the characteristic abnormalities in psoriasis is the excessive production of …

The pathogenesis of obesity and dyslipidemia involves genetic factors, such as
polymorphisms related to lipid metabolism alterations predisposing their development. This …

Background Psoriasis is an inflammatory disease associated with multiple comorbidities.
Biomarkers for the assessment of psoriasis, its associated comorbidities, and the therapeutic …

Background Obesity is a leading comorbidity in psoriatic disease, including both psoriasis
(PsO) and psoriatic arthritis (PsA), and is associated with adverse metabolic and …